Cargando…
The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model
BACKGROUND: Weight gain is one of the consequences of estrogen deficiency and constitutes a major health problem. The present study highlights the effects of N-methyl pyrrolidone (NMP) on adipogenesis in osteoporosis induced by estrogen deficiency in an ovariectomized rat model. RESULTS: Ovariectomy...
Autores principales: | Gjoksi, Bebeka, Ghayor, Chafik, Bhattacharya, Indranil, Zenobi-Wong, Marcy, Weber, Franz E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840488/ https://www.ncbi.nlm.nih.gov/pubmed/27110299 http://dx.doi.org/10.1186/s13148-016-0209-2 |
Ejemplares similares
-
The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes
por: Siegenthaler, Barbara, et al.
Publicado: (2018) -
N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment
por: Ghayor, Chafik, et al.
Publicado: (2017) -
Effect of N-Vinyl-2-Pyrrolidone (NVP), a Bromodomain-Binding Small Chemical, on Osteoblast and Osteoclast Differentiation and Its Potential Application for Bone Regeneration
por: Klemmer, Viviane A., et al.
Publicado: (2021) -
N,N-Dimethlyacetamide Prevents the High-Fat Diet-Induced Increase in Body Weight
por: Bhattacharya, Indranil, et al.
Publicado: (2019) -
The Release of the Bromodomain Ligand N,N-Dimethylacetamide Adds Bioactivity to a Resorbable Guided Bone Regeneration Membrane in a Rabbit Calvarial Defect Model
por: Siegenthaler, Barbara, et al.
Publicado: (2020)